AIM
Aigen Investment Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.34M | Buy |
68,321
+3,509
| +5% | +$377K | 1.01% | 2 |
|
|
2025
Q1 | $6.54M | Buy |
+64,812
| New | +$6.54M | 1.04% | 2 |
|
|
2024
Q4 | – | Sell |
-6,761
| Closed | -$567K | – | 748 |
|
|
2024
Q3 | $567K | Buy |
+6,761
| New | +$567K | 0.11% | 285 |
|
|
2024
Q2 | – | Sell |
-32,563
| Closed | -$2.23M | – | 790 |
|
|
2024
Q1 | $2.23M | Buy |
+32,563
| New | +$2.23M | 0.49% | 36 |
|
|
2023
Q3 | – | Sell |
-20,665
| Closed | -$1.12M | – | 841 |
|
|
2023
Q2 | $1.12M | Buy |
+20,665
| New | +$1.12M | 0.17% | 173 |
|
|
2022
Q1 | – | Sell |
-32,038
| Closed | -$1.26M | – | 597 |
|
|
2021
Q4 | $1.26M | Buy |
+32,038
| New | +$1.26M | 0.08% | 344 |
|
|
2021
Q1 | – | Sell |
-22,977
| Closed | -$826K | – | 640 |
|
|
2020
Q4 | $826K | Buy |
22,977
+15,919
| +226% | +$572K | 0.11% | 249 |
|
|
2020
Q3 | $270K | Buy |
+7,058
| New | +$270K | 0.03% | 571 |
|
|
2020
Q2 | – | Sell |
-148,603
| Closed | -$4.85M | – | 860 |
|
|
2020
Q1 | $4.85M | Buy |
+148,603
| New | +$4.85M | 0.64% | 12 |
|